Antisense & RNAi Therapeutics Market Insights, Trends and Precise Outlook- Biogen Inc.; Ionis Pharmaceuticals, Inc.; Alnylam Pharmaceuticals, Inc.; Arrowhead Pharmaceuticals

Antisense & RNAi Therapeutics Market 2021 report helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market- driven results deriving feasibility studies for client needs. Market Insights Reports ensures qualified and verifiable aspects of market data operating in the real- time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in the real- time scenario.

SPECIAL OFFER (Avail an Up-to 25% discount on this report, please fill the form and mention the code: MIR30 in the comments section)

Click the link to get a Free Sample Copy of the Report @:

https://www.marketinsightsreports.com/reports/05182898453/antisense-rnai-therapeutics-global-market-opportunities-and-strategies-to-2030-covid-19-growth-and-change-including-the-global-antisense-rnai-therapeutics-market-is-segmented-into-1-by-technology-rna-interference-antisense-rna-2-by-route-of-administration-intravenous-injections-intra-dermal-injections-other-delivery-methods-3-by-indication-oncology-cardiovascular-diseases-respiratory-disorders-neurological-disorders-infectious-diseases-other-diseases-covering-biogen-inc-ionis-pharmaceuticals-inc-alnylam-pharmaceuticals-inc-arrowhead-pharmaceuticals-inc-moderna-inc-sanofi-s-a-dicerna-pharmaceuticals-inc/inquiry?Mode=Saiba

The global antisense and RNAi therapeutics market reached a value of nearly $3,677.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 38.2% since 2017

Top leading Companies Profiled in Antisense & RNAi Therapeutics Market Report are Biogen Inc.; Ionis Pharmaceuticals, Inc.; Alnylam Pharmaceuticals, Inc.; Arrowhead Pharmaceuticals, Inc.; Moderna, Inc.; Sanofi S.A.; Dicerna Pharmaceuticals, Inc.

Markets Segmentation:

1) By Technology: RNA Interference; Antisense RNA

2) By Route Of Administration: Intravenous Injections; Intra-Dermal Injections; Other Delivery Methods

3) By Indication: Oncology; Cardiovascular Diseases; Respiratory Disorders; Neurological Disorders; Infectious Diseases; Other Diseases

Regional Analysis:

Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), North America (United States, Canada, and Mexico), Central & South America (Brazil, and Rest of South America), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other)

Market Overview

The market is expected to grow from $3,677.3 million in 2020 to $5,660.6 million in 2025 at a rate of 9.0%. The growth is mainly due to the growing demand for antisense and RNAi therapeutics due to COVID-19 which is expected to drive the demand for antisense and RNAi therapeutics. The market is expected to grow to $8,261.2 million in in 2030 at a CAGR of 7.9%.

Growth in the historic period resulted from rise in funding, advancement in technologies, and rise in healthcare expenditure, rapid growth in elderly population and economic growth in emerging markets. This growth was restricted by regulatory challenges and delivery challenges.

Going forward, increase in healthcare access, rising prevalence of caner and increasing demand for antisense and RNAi therapeutics due to COVID-19 are expected to drive the market. High costs of tests, rising popularity of competing products and difficulty in manufacturing and transporting antisense and RNAi therapeutics are major factors that could hinder the growth of the antisense and RNAi therapeutics market in the future.

The antisense and RNAi therapeutics market is segmented by technology into RNA interference and antisense RNA. The antisense RNA market was the largest segment of the antisense and RNAi therapeutics market by technology, accounting for 94.9% of the total market in 2020. Going forward, RNA interference segment is expected to be the fastest growing segment in the antisense and RNAi therapeutics market, at a CAGR of 20.1%.

The antisense and RNAi therapeutics market is also segmented by route of administration into intravenous injections, intra-dermal injections, and other delivery methods. The intravenous injections market was the largest segment of the antisense and RNAi therapeutics market by route of administration, accounting for 93.8% of the total market in 2020. Going forward, the intra-dermal segment is expected to be the fastest growing segment in the antisense and RNAi therapeutics market, at a CAGR of 26.9%.

The antisense and RNAi therapeutics market is also segmented by indication into oncology, cardiovascular diseases (CVD), respiratory disorders, neurological disorders, and infectious diseases and other diseases. The neurological disorders market was the largest segment of the antisense and RNAi therapeutics market by indication, accounting for 89.5% of the total market in 2020. Going forward, the infectious diseases segment is expected to be the fastest growing segment in the antisense and RNAi therapeutics market, at a CAGR of 88.4%.

The antisense and RNAi therapeutics market is also segmented by geography into Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Western Europe was the largest region in the global antisense and RNAi therapeutics market, accounting for 52.0% of the total in 2020. It was followed by the North America, Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the antisense and RNAi therapeutics market will be Middle East and Africa, where growth will be at CAGRs of 22.5% and 17.9% respectively. These will be followed by Asia Pacific and South America, where the markets are expected to register CAGRs of 15.8% and 15.0% respectively.

The antisense & RNAi therapeutics market is highly concentrated, with a small number of large players. The top ten competitors in the market made up to 95.74% of the total market in 2019. Major players in the market include Biogen Inc., Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Moderna, Inc. and others.

Get Benefited discount at:

https://www.marketinsightsreports.com/reports/05182898453/antisense-rnai-therapeutics-global-market-opportunities-and-strategies-to-2030-covid-19-growth-and-change-including-the-global-antisense-rnai-therapeutics-market-is-segmented-into-1-by-technology-rna-interference-antisense-rna-2-by-route-of-administration-intravenous-injections-intra-dermal-injections-other-delivery-methods-3-by-indication-oncology-cardiovascular-diseases-respiratory-disorders-neurological-disorders-infectious-diseases-other-diseases-covering-biogen-inc-ionis-pharmaceuticals-inc-alnylam-pharmaceuticals-inc-arrowhead-pharmaceuticals-inc-moderna-inc-sanofi-s-a-dicerna-pharmaceuticals-inc/discount?Mode=Saiba

Key Takeaways from Antisense & RNAi Therapeutics Report

─Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals

─Understand the different dynamics influencing the Antisense & RNAi Therapeutics market – key driving factors, challenges and hidden opportunities.

─Get in-depth insights on your competitor performance – Antisense & RNAi Therapeutics market shares, strategies, financial benchmarking, product benchmarking, SWOT and more

─Analyze the sales and distribution channels across key geographies to improve top-line revenues.

─Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

─Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

─Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the Antisense & RNAi Therapeutics

Buy Now This Report at

https://www.marketinsightsreports.com/report/purchase/05182898453?mode=su?Mode=Saiba

In conclusion, the Antisense & RNAi Therapeutics market report presents the descriptive analysis of the parent market supported elite players, present, past and artistic movement information which is able to function as a profitable guide for all the Antisense & RNAi Therapeutics Industry business competitors. Our expert research analyst’s team has been trained to provide in-depth market research reports from every individual sector which will be helpful to understand the industry data in the most precise way.

Available Customization– The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234
Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.